Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mineralocorticoid Receptor Antagonist”

69 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 69 results

Large-scale testing (Phase 3)Study completedNCT02807987
What this trial is testing

Study of CS-3150 in Combination With ARB or ACE Inhibitor in Hypertensive Patients With Moderate Renal Impairment

Who this might be right for
Hypertension With Moderate Renal Impairment
Daiichi Sankyo Co., Ltd. 58
Large-scale testing (Phase 3)Looking for participantsNCT06033950
What this trial is testing

Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists

Who this might be right for
Heart Failure
Colorado Prevention Center 2,600
Post-approval studies (Phase 4)Study completedNCT06381323
What this trial is testing

The Clinical Efficacy and Safety of Finerenone in the Treatment of Primary Aldosteronism

Who this might be right for
Primary AldosteronismFinerenoneMineralocorticoid Receptor Antagonist
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 55
Not applicableStudy completedNCT05526157
What this trial is testing

An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes Mellitus
Bayer 50,000
Large-scale testing (Phase 3)Study completedNCT02040441
What this trial is testing

Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria

Who this might be right for
Diabetic NephropathyDiabetic Retinopathy
Peter Rossing 1,777
Testing effectiveness (Phase 2)Study completedNCT02497300
What this trial is testing

Vascular Effects of Mineralocorticoid Receptor Antagonism in Kidney Disease

Who this might be right for
Chronic Kidney DiseaseAlbuminuria
University of Alabama at Birmingham 21
Not applicableStudy completedNCT02885662
What this trial is testing

Study of CS-3150 in Patients With Primary Aldosteronism

Who this might be right for
Primary Aldosteronism
Daiichi Sankyo Co., Ltd. 44
Post-approval studies (Phase 4)Study completedNCT01837108
What this trial is testing

Eplerenone and Extracellular Adenosine Formation

Who this might be right for
Pharmacodynamics
Radboud University Medical Center 14
Not applicableLooking for participantsNCT05797558
What this trial is testing

Unilateral Primary Aldosteronism, Mineralocorticoid Antagonists Versus Surgical Treatment

Who this might be right for
Primary Hyperaldosteronism Due to Adrenal Adenoma
Göteborg University 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Large-scale testing (Phase 3)Study completedNCT02722265
What this trial is testing

Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 368
Testing effectiveness (Phase 2)Looking for participantsNCT06906081
What this trial is testing

Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study

Who this might be right for
Cardiovascular Autonomic NeuropathyType 2 DiabetesDiabetic Neuropathies
Peter Rossing 100
Not applicableStudy completedNCT05275920
What this trial is testing

Building Electronic Tools To Enhance and Reinforce CArdiovascular REcommendations - Heart Failure (BETTER CARE-HF)

Who this might be right for
Heart FailureHeart Failure With Reduced Ejection Fraction
NYU Langone Health 2,211
Not applicableStudy completedNCT02740179
What this trial is testing

Effects of Eplerenone on Cardiovascular Disease in HIV (MIRACLE HIV Study)

Who this might be right for
HIV
Massachusetts General Hospital 40
Post-approval studies (Phase 4)UnknownNCT01510795
What this trial is testing

Mineralocorticoid Receptor Antagonist and Kidney Allograft Histology

Who this might be right for
Kidney Failure, Chronic
Clinical Hospital Merkur 40
Not applicableUnknownNCT05262660
What this trial is testing

The Long-term Effect of SAAE and Medical Treatment for Primary Aldosteronism

Who this might be right for
Primary Aldosteronism
First Affiliated Hospital of Chengdu Medical College 400
Not applicableStudy completedNCT02848170
What this trial is testing

Study of CS-3150 Compared to Olmesartan in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 40
Not applicableStudy completedNCT03174847
What this trial is testing

Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism

Who this might be right for
Primary AldosteronismPrimary Aldosteronism Due to Aldosterone Producing AdenomaPrimary Aldosteronism Due to Adrenal Hyperplasia (Bilateral)
Changi General Hospital 57
Not applicableStudy completedNCT03789357
What this trial is testing

Prevalence of Primary Aldosteronism in Patients With Stroke

Who this might be right for
Primary AldosteronismStroke
Changi General Hospital 300
Large-scale testing (Phase 3)Study completedNCT02890173
What this trial is testing

Study of CS-3150 in Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
Daiichi Sankyo Co., Ltd. 1,001
Load More Results